Company: EDSA
Filing Date: 2025-03-11
Form Type: 424B3
Source: 0001171843-25-001403
Chunk: 7

Company: Edesa Biotech, Inc.
Filing Date: 2025-03-11
Form: 424B3
Chunk 7
---
 anticipate will or may occur in the future are forward-looking statements. Our forward-looking statements generally
include statements about our plans, objectives, strategies and prospects regarding, among other things, our businesses, results of operations,
liquidity and financial condition. In some cases, we have identified these forward-looking statements with words like “believe,”
“may,” “could,” “might,” “possible,” “potential,” “project,”
“will,” “should,” “expect,” “intend,” “plan,” “predict,” “anticipate,”
“estimate,” “approximate,” “contemplate” or “continue,” or the negative of these words
or other words and terms of similar meaning. Known and unknown risks and uncertainties could cause our actual results to differ materially
from those in forward-looking statements. Such risks include, but are not limited to, the following:

| · | our ability to obtain funding for our operations; |

| · | our estimates regarding our expenses, revenues, anticipated capital requirements and our needs for additional financing; |

| · | the timing of the commencement, progress and receipt of data from any of our preclinical and clinical trials; |

| · | the expected results of any preclinical or clinical trial and the impact on the likelihood or timing of any regulatory approval; |

| · | the therapeutic benefits, effectiveness and safety of our product candidates; |

| · | the timing or likelihood of regulatory filings and approvals; |

| · | changes in our strategy or development plans; |

| · | the volatility of our common share price; |

| · | the rate and degree of market acceptance and clinical utility of any future products; |

| · | the effect of competition; |

| · | our ability to protect our intellectual property as well as comply with the terms of license agreements with third parties; |

| · | our ability to comply with the continued listing requirements of the Nasdaq Capital Market; |

| · | our ability to identify, develop and commercialize additional products or product candidates; |

| · | reliance on key personnel; and |

| · | general changes in economic or business conditions. |

More detailed information about these
and other factors is included under “Risk Factors” in this and in other documents incorporated herein by reference. Many of
these factors are beyond our control. Future events may vary substantially from what we currently foresee. You should not place undue
reliance on such forward- looking statements. We are under no obligation to update or alter such forward-looking statements whether as